US loss of exclusivity · Other

Ultomiris

AstraZeneca

2035US biosimilars from
2025Today: 20262037
2025 worldwide sales
$4.7B
Date basis
Company guidance
US biosimilars
No US filing found
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Ultomiris timeline →